RxDoctor Payments Data

Shobha Shakamuri, MD

Nephrology · Longview, TXNPI 1902861446

Payments from drug & device makers

$133in general payments, 2019–2025

Across 8 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$64
  • Vifor Pharma, Inc.$26
  • AstraZeneca$16
  • Akebia Therapeutics Inc$14
  • Mallinckrodt Enterprises LLC$13
  • Travere Therapeutics, Inc.$0

What the payments were for

  • Food & beverage$132100%
  • Education$00%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$133 in reported general payments places this provider in the 10th percentile of 1,070 nephrology providers in Texas.

See all nephrology providers in Texas

Medicare billing

Part B allowed, 2024
$144,108
Medicare patients
242
Services billed
1,148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Midodrine Hcl18$372
Nifedipine ErNifedipine11$122
Levothyroxine Sodium11$77

Paid to pharmacies, not to this prescriber.

Other nephrology in Longview

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →